| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACC.2016.02.013 |
| P698 | PubMed publication ID | 27081020 |
| P50 | author | Philipp Lurz | Q65548833 |
| Suzanne de Waha | Q65548837 | ||
| Matthias Gutberlet | Q65548840 | ||
| Ingo Eitel | Q65548845 | ||
| Reinhard Kandolf | Q84837539 | ||
| Karin Klingel | Q87691907 | ||
| Matthias Grothoff | Q88186770 | ||
| Holger Thiele | Q96232898 | ||
| Gerhard Schuler | Q104070983 | ||
| Christian Luecke | Q114420233 | ||
| Karl-Philipp Rommel | Q114776956 | ||
| P2093 | author name string | Julia Anna Lurz | |
| Clara Frank | |||
| Felix Föhrenbach | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| myocarditis | Q186235 | ||
| cardiac magnetic resonance imaging | Q5038325 | ||
| P304 | page(s) | 1800-1811 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial | |
| P478 | volume | 67 |
| Q96304402 | (Epicardial and microvascular) angina or atypical chest pain: differential diagnoses with cardiovascular magnetic resonance |
| Q41696273 | A novel multiparametric imaging approach to acute myocarditis using T2-mapping and CMR feature tracking |
| Q37510974 | A retrospective study: cardiac MRI of fulminant myocarditis in children-can we evaluate the short-term outcomes? |
| Q37726262 | Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis |
| Q57149070 | Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment |
| Q61800819 | Acute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonance |
| Q49549449 | Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis |
| Q42374261 | Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis |
| Q64965888 | Advances in Cardiovascular MRI using Quantitative Tissue Characterisation Techniques: Focus on Myocarditis. |
| Q92501431 | Assessment of sympathetic reinnervation after cardiac transplantation using hybrid cardiac PET/MRI: A pilot study |
| Q89161719 | CMR-guidance of passively tracked endomyocardial biopsy in an in vivo porcine model |
| Q92227202 | Cardiac Magnetic Resonance Fingerprinting: Technical Developments and Initial Clinical Validation |
| Q90206724 | Cardiac magnetic resonance imaging: the future is bright |
| Q90030540 | Cardiovascular immune-related adverse events: Evaluation, diagnosis and management |
| Q97645778 | Cardiovascular magnetic resonance imaging for inflammatory heart diseases |
| Q42373017 | Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular |
| Q47297387 | Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction |
| Q64089087 | Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis |
| Q36082418 | Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute Myocarditis |
| Q92163839 | Computational Identification of Ventricular Arrhythmia Risk in Pediatric Myocarditis |
| Q38830086 | Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care |
| Q56348168 | Diagnostic Performance of Extracellular Volume, Native T1, and T2 Mapping Versus Lake Louise Criteria by Cardiac Magnetic Resonance for Detection of Acute Myocarditis: A Meta-Analysis |
| Q90394786 | Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis |
| Q91895086 | Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis |
| Q36370824 | Feature-tracking myocardial strain analysis in acute myocarditis: diagnostic value and association with myocardial oedema. |
| Q88051837 | Fulminant myocarditis: Characteristics, treatment, and outcomes |
| Q90059150 | How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
| Q57138278 | Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM) |
| Q57163501 | Hybrid positron emission tomography-magnetic resonance of the heart: current state of the art and future applications |
| Q49331322 | Iatrogenic myocarditis-biomarkers, cardiovascular MRI and the need for early diagnosis. |
| Q95592177 | Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment |
| Q55494001 | Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping. |
| Q50945971 | Lost in markers? Time for phenomics and phenomapping in dilated cardiomyopathy. |
| Q90569797 | Machine learning in cardiovascular magnetic resonance: basic concepts and applications |
| Q38736889 | Magnetic resonance imaging for characterizing myocardial diseases |
| Q38741514 | Map to the future of cardiac magnetic resonance in myocarditis |
| Q92962760 | Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches |
| Q52670629 | Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography. |
| Q46786121 | Myocardial edema in acute myocarditis: relationship of T2 relaxometry and late enhancement burden by using dual-contrast turbo spin-echo MRI. |
| Q100526188 | Myocarditis and inflammatory cardiomyopathy: current evidence and future directions |
| Q64916705 | Myocarditis in Humans and in Experimental Animal Models. |
| Q47998095 | Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure. |
| Q89668418 | Myocarditis presenting as typical acute myocardial infarction: A case report and review of the literature |
| Q89476642 | Myoglobin for Detection of High-Risk Patients with Acute Myocarditis |
| Q47608249 | Native T1 reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: A systematic review and meta-analysis |
| Q50077347 | Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping. |
| Q64912580 | Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up. |
| Q33844251 | PET-CMR in heart failure - synergistic or redundant imaging? |
| Q41283268 | Performance of Cardiac Magnetic Resonance Imaging for Diagnosis of Myocarditis Compared with Endomyocardial Biopsy: A Meta-Analysis |
| Q48203790 | Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques |
| Q59355085 | Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy |
| Q50061111 | Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis |
| Q38705855 | Re-evaluation of a novel approach for quantitative myocardial oedema detection by analysing tissue inhomogeneity in acute myocarditis using T2-mapping |
| Q47129985 | Supplementary Diagnostic Landmarks of Left Ventricular Non-Compaction on Magnetic Resonance Imaging |
| Q98458127 | T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction |
| Q33844044 | T1 mapping in cardiac MRI. |
| Q33844225 | T2 mapping and T2* imaging in heart failure |
| Q47599705 | T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. |
| Q30845809 | Targeted endomyocardial biopsy guided by real-time cardiovascular magnetic resonance |
| Q87659738 | The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure |
| Q52660853 | Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy. |
Search more.